Related Experiment Videos
Abstract:
In considering the clinical aspects of fungal sensitivity, assessing exposure potential and clinical testing are essential. Valid prevalence data are difficult to secure. For ambient air, the Burkard Volumetric Spore Traps, or equal, capture spores best. For in-home analysis for fungi, the history and personal inspection of the house remains the most available method of assessment. Allergy skin test material is unavailable for most airborne fungi. Those that are available are not standardized. Yet the practicing allergist/clinical immunologist must select what fungal extract are available based on air sampling data and personal exposure of the patient. A major management approach with patients with proven sensitivity to fungal antigens and a clear correlation with clinical illness is avoidance of fungal sources. Immunotherapy should be considered when avoidance and well tolerated pharmacotherapy are ineffective in controlling the patient's symptoms.
Insights
Assessing fungal sensitivity involves evaluating exposure and testing, though standardized allergy tests are limited. Management focuses on avoiding fungal sources and considering immunotherapy if needed.
Area of Science:
- Clinical immunology
- Environmental health
Background:
- Fungal sensitivity assessment is crucial for clinical management.
- Accurate prevalence data for airborne fungi are challenging to obtain.
- Standardized allergy testing materials for airborne fungi are largely unavailable.
Purpose of the Study:
- To outline essential considerations for assessing fungal sensitivity in patients.
- To discuss methods for evaluating fungal exposure potential.
- To guide allergists in managing patients with fungal allergies.
Main Methods:
- Utilizing volumetric spore traps for ambient air sampling.
- Employing patient history and home inspection for in-home fungal assessment.
- Selecting available, albeit non-standardized, fungal extracts for testing.
Main Results:
- Burkard Volumetric Spore Traps are effective for ambient air spore capture.
- Patient history and home inspection are primary methods for in-home fungal exposure assessment.
- Allergists must choose from limited, non-standardized fungal extracts for clinical testing.
Conclusions:
- Effective management of fungal sensitivity relies on assessing exposure and utilizing available testing.
- Avoiding fungal sources is a primary strategy for patients with proven sensitivity.
- Immunotherapy is a viable option when avoidance and pharmacotherapy fail.